According to GlobalData’s medical device pipeline database, 19 Helicobacter pylori Tests devices are in various stages of development globally. GlobalData’s report Helicobacter pylori Tests provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Smarter leaders trust GlobalData
Of these devices, nine are in active development, while the remaining 11 are in an inactive stage of development. There are four products in the early stages of development, and the remaining five are in the late stages of development.
In Vitro Diagnostics (IVD) include reagents, instruments, and systems intended for use in the diagnosis of disease or other conditions, including the determination of the state of health, in order to treat or prevent disease. The reagents, instruments and systems are intended for use in the collection, preparation, and examination of specimens taken from the human body. The categories tracked under this market are Cardiac Disease, Hematological Disorders, Hormonal Disorders, Metabolic Disorder, Infectious Disease, IVD Analyzers and Reagents, Oncology and Reproductive Health Diagnostics. Helicobacter pylori tests are used to diagnose stomach infections caused by the bacterium, Helicobacter pylori (previously known as Campylobacter pylori), which are associated with gastritis (stomach inflammation), ulcers of the stomach or first part of the small intestine, and, in some cases, cancer. The Helicobacter pylori test market includes Helicobacter pylori Breath Tests, Helicobacter pylori Feces Tests, Helicobacter pylori Serology Enzyme Immuno Assay (EIA) Tests, Helicobacter pylori Rapid Urease Tests, Helicobacter pylori Immunohistochemical (IHC) Tests and Helicobacter Pylori Other Tests.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Helicobacter pylori Tests pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Helicobacter pylori Tests devices. Overall, most of these Helicobacter pylori Tests pipeline devices are being developed by private entities.
Key players involved in the active development of Helicobacter pylori Tests include Meridian Bioscience, Otsuka Medical Devices, Guangzhou Wondfo Biotech, HA TECH, ImmunoScience, Salignostics, University of Texas Medical Branch at Galveston, Adaltis, BBB Technologies and Bio-AMD.
For a complete picture of the developmental pipeline for Helicobacter pylori Tests devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. The Pipeline Products database is a is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
